��������

Bin Pan currently serves as the Executive Director and Head of Hematology/Oncology at TFS, with responsibilities encompassing strategic planning, business development, and operational delivery for the hematology/oncology business unit. Prior experience includes a role as Director of Oncology Strategy at IQVIA Biotech, following the transition from Novella Clinical, and various positions in clinical research and management at companies such as SGS, ReSearch Pharmaceutical Services, Amgen, PPD, Roche, and the University of California, San Francisco. Bin Pan holds a Doctor of Philosophy (PhD) from the University of Minnesota.